BICO Group AB
OTC:CLLKF

Watchlist Manager
BICO Group AB Logo
BICO Group AB
OTC:CLLKF
Watchlist
Price: 2 USD Market Closed
Market Cap: $138.1m

Relative Value

The Relative Value of one CLLKF stock under the Base Case scenario is 4.73 USD. Compared to the current market price of 2 USD, BICO Group AB is Undervalued by 58%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CLLKF Relative Value
Base Case
4.73 USD
Undervaluation 58%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

CLLKF Competitors Multiples
BICO Group AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
BICO Group AB
OTC:CLLKF
1.3B USD 0.9 -1.9 0.3 -1.3
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 460.4 5 453.9 1 599.2 3 212.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD 5.4 36 25.5 32.9
US
Danaher Corp
NYSE:DHR
165.5B USD 6.8 47.2 25.3 38.2
CH
Lonza Group AG
SIX:LONN
37.6B CHF 5.4 51.9 39.1 39.1
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD 2.5 31.3 15 22.6
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY 6.3 18.7 18.8 18.8
US
Agilent Technologies Inc
NYSE:A
38.2B USD 5.5 29.3 22.7 27.1
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD 7.3 34.2 24.7 27.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR 6.9 76.6 27.1 44.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
BICO Group AB
OTC:CLLKF
Average EV/EBIT: 348.6
Negative Multiple: -1.3
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 212.8
29%
110.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
32.9
15%
2.2
US
Danaher Corp
NYSE:DHR
38.2
16%
2.4
CH
Lonza Group AG
SIX:LONN
39.1
22%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
22.6
14%
1.6
CN
WuXi AppTec Co Ltd
SSE:603259
18.8
23%
0.8
US
Agilent Technologies Inc
NYSE:A
27.1
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
22.5
28%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
27.4
6%
4.6
FR
Sartorius Stedim Biotech SA
PAR:DIM
44.5
31%
1.4